Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11290	Companies
250881	Keywords
179710	Articles
136718	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 3 months 7 days ago

Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de sa cotation sur Euronext Growth Paris. Les résultats financiers montrent une amélioration malgré une perte nette de 8,2 M€

Résultats Financiers Biophytis Cotation Comptes Annuels Perte Nette
REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 3 months 7 days ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% compared to 2024

Financial Statements Biophytis Financial Debt Trading Resumption Liabilities
PRESS RELEASE

published on 07/29/2026 at 22:59, 3 months 7 days ago

Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action sur Euronext Growth Paris. Les résultats financiers et opérationnels sont présentés ainsi que la situation de trésorerie

Résultats Financiers Euronext Growth Paris Biophytis Trésorerie Comptes Annuels
PRESS RELEASE

published on 07/29/2026 at 22:59, 3 months 7 days ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% in 2025. Net loss improved by 13% compared to 2024

Financial Statements Biophytis Trading Net Loss Financial Debt
BRIEF

published on 07/01/2026 at 07:05, 4 months 5 days ago

Biophytis : Résultats financiers provisoires 2025 et nouvelles stratégies

Résultats Financiers Biophytis Sarcopénie Continuité D'exploitation Joint-venture Asie
BRIEF

published on 07/01/2026 at 07:05, 4 months 5 days ago

Biophytis Reports 2025 Financial Outcomes and Strategic Plans

Regulatory Milestones Asian Joint Venture Biophytis Financial Results Sarcopenia Clinical Trials Cash Flow Uncertainty
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 4 months 5 days ago

BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Biophytis reports provisional financial results for fiscal year 2025 and strategic outlook, including milestones in sarcopenia and obesity programs, engagement with scientific community, and financial restructuring

Biophytis Sarcopenia Obesity Strategic Outlook Provisional Financial Results
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 4 months 5 days ago

Biophytis communique ses résultats financiers provisoires et partage ses perspectives stratégiques
Biophytis communique ses résultats financiers provisoires pour l'exercice 2025 et partage ses perspectives stratégiques, incluant des avancées dans la sarcopénie et l'obésité

Résultats Financiers Biophytis Sarcopénie Obésité Perspectives Stratégiques
BRIEF

published on 06/15/2026 at 23:05, 4 months 20 days ago

Suspension provisoire de la cotation de Biophytis

Biophytis Actions Euronext Growth Suspension Cotation Retard Rapport Financier
BRIEF

published on 06/15/2026 at 23:05, 4 months 20 days ago

Biophytis Temporarily Suspends Share Trading

Biophytis Financial Report Euronext Growth Share Suspension Operational Delay

Accesswire

Published on 11/06/2026 at 05:15, 4 hours 35 minutes ago

Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 01:20, 8 hours 30 minutes ago

Presentation to Munich Mining Conference
Published on 11/06/2026 at 00:53, 8 hours 57 minutes ago

Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 9 hours 5 minutes ago

Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 9 hours 55 minutes ago

Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19

View all ACCESSWIRE

EQS Group

Published on 11/06/2026 at 09:42, 7 minutes ago

Silver for the Thorium Pioneer: Emerald Horizon Takes Second Place at “Innovator of the Year” 2026
Published on 11/06/2026 at 09:10, 40 minutes ago

Rentschler Biopharma Receives the Business Medal of the State of Baden-Wuerttemberg
Published on 11/06/2026 at 09:04, 45 minutes ago

PARMANTIER & CIE. appoints Stefan Heieck and Harry Tyser as Senior Advisors
Published on 11/06/2026 at 09:01, 49 minutes ago

Original-Research: Nynomic AG (von NuWays AG): BUY
Published on 11/06/2026 at 09:00, 50 minutes ago

Nexum Group Listing – Trading on the Frankfurt Stock Exchange's Regulated Market has begun

Les Echos

Published on 11/06/2026 at 09:07, 43 minutes ago

Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Published on 11/06/2026 at 09:04, 45 minutes ago

Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Published on 11/05/2026 at 18:21, 15 hours 28 minutes ago

Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 15 hours 28 minutes ago

Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 18:01, 15 hours 49 minutes ago

LNA SANTE : Chiffre d'Affaires T3 2026

View all LES ECHOS COMFI WIRE